Deals
Deal activity by volume related to artificial intelligence increased by 1% year-on-year in 2022 in the medical device industry
Credit: Bert van Dijk/Getty images.
Powered by
Aalysis of the key themes driving deal activity reveals that artificial intelligence accounted for 1,817 medical device deals between 2018 and 2022, worth a total value of $75.963m, according to GlobalData’s Deals database covering mergers and acquisitions, private equity, venture financing, equity offerings and partnerships.
The $75m venture financing of RapidSOS was the largest disclosed deal in 2022, while the $2,339m merger of GS Acquisition with Mirion Technologies was the largest disclosed deal in 2021.
In volume terms, artificial intelligence related deal activity increased by 1% year-on-year in 2022 and decreased by 8% year-on-year in 2021.
Deal activity related to artificial intelligence in the global medical device industry in the last five years
Top deals related to artificial intelligence in the medical device industry in the last five years
Deal volume by deal type for artificial intelligence related deals in the medical device industry in the last five years
Venture financing accounted for the highest number of deals in the last five years, with 1,009 deals, followed by partnership (440 deals), and equity offering (156 deals).
Top financial advisors for artificial intelligence related deals by value in the medical device industry in the last five years
The top financial advisors supporting deals related to artificial intelligence in the medical device industry in the last five years in terms of value were Lazard, Goldman Sachs, Morgan Stanley, UBS Group, and BofA Securities.
Top legal advisors for artificial intelligence related deals by value in the medical device industry in the last five years
The top legal advisors supporting deals related to artificial intelligence in the medical device industry in the last five years in terms of value were Latham & Watkins; Paul, Weiss, Rifkind, Wharton & Garrison; Wilmer Cutler Pickering Hale and Dorr; Davis Polk & Wardwell London; and Gibson, Dunn & Crutcher.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Deals database provides comprehensive coverage across industries tracking market activity of global mergers & acquisitions, including asset acquisitions/divestments; private equity deals (PE); venture finance deals (VC); equity offerings, including IPOs, follow-on offerings, and private placements; debt offerings, including private placements, ESG bonds and loans; partnerships; and licensing agreements.
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals.
